EPHX2 and obesity disorder: Overall, the results suggest that the fatty acid diol reduction may be associated broadly with obesity and reduced sEH activity (increased 12,13-EpOME:DiHOME) is indicative of metabolic dysfunction characterized by WAT inflammation and hepatic steatosis.